Skip to main content
logo
Daiken Medical Co., Ltd. (TYO:7775)
Japan flag Japan · Delayed Price · Currency is JPY
421.00
+1.00 (0.24%)
Aug 5, 2026, 3:30 PM JST

Daiken Medical Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
10,23210,2909,9519,7509,1378,540
Revenue Growth
1.77%3.41%2.06%6.71%6.99%8.64%
Gross Profit
3,8553,9504,0963,9823,5303,684
Operating Income
1,2091,2771,5121,4431,0551,151
Net Income
873.499221,097988712831
Earnings Per Share
30.4032.0938.1934.3924.7828.93
EPS Growth
-14.66%-15.95%11.03%38.76%-14.32%23.11%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2,4352,7782,9952,7392,5162,518
Total Debt
2,1122,2682,0512,1422,7552,933
Net Cash (Debt)
323510944597-239-415
Net Cash Growth
-54.05%-45.98%58.12%---
Net Cash Per Share
11.2417.7532.8620.78-8.32-14.45

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-5671,1201,5559891,133
Capital Expenditures
--327-166-162-198-202
Free Cash Flow
-2409541,393791931
Free Cash Flow Growth
--74.84%-31.51%76.11%-15.04%210.33%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
37.68%38.39%41.16%40.84%38.63%43.14%
Operating Margin
11.82%12.41%15.19%14.80%11.55%13.48%
Pretax Margin
11.48%12.10%15.14%14.72%11.21%13.48%
Profit Margin
8.54%8.96%11.02%10.13%7.79%9.73%
FCF Margin
-2.33%9.59%14.29%8.66%10.90%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
13.8513.9612.8316.1419.4117.63
P/FCF Ratio
50.3953.6314.7611.4517.4715.74
PS Ratio
1.181.251.421.641.511.72